NDC 63759-3032 – Bortezomib
Bortezomib 3.5 mg/1.4mL · Injection · Intravenous, Subcutaneous
Product NDC63759-3032
Product details
- Brand name
- Bortezomib
- Generic name
- Bortezomib
- Labeler
- Shilpa Medicare Limited
- Dosage form
- Injection
- Route
- Intravenous, Subcutaneous
- Marketing category
- NDA · NDA212782
- Marketed since
- September 25, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Proteasome Inhibitor
Active ingredients
- Bortezomib 3.5 mg/1.4mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 63759-3032-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63759-3032-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE | Sep 25, 2024 |
Other Bortezomib products
- 70511-162 Bortezomib 2.5 mg/1 · Injection · MAIA Pharmaceuticals, Inc.
- 70511-161 Bortezomib 1 mg/1 · Injection · MAIA Pharmaceuticals, Inc.
- 60505-6050 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Apotex Corp
- 83634-208 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Avenacy, LLC
- 68001-540 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 68001-541 Bortezomib 3.5 mg/3.5mL · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 68001-534 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 31722-303 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Camber Pharmaceuticals, Inc.
- 43598-426 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Dr.Reddy's Laboratories, Inc.
- 55150-337 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 63323-821 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Fresenius Kabi USA, LLC
- 68083-651 Bortezomib 2.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited